News & Updates
Filter by Specialty:
Show Multimedia Only
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
a day ago
byMike Ng
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
a day ago
Exercise prevents death in diabetes patients with MI
a day ago
byStephen Padilla
Regularly engaging in any physical activity (PA) can help reduce the risk of death in patients with diabetes and myocardial infarction (MI), suggests a study presented at ADA 2025.
Exercise prevents death in diabetes patients with MI
a day ago
Lorundrostat for uncontrolled hypertension hits efficacy, safety targets in phase III trial
10 Jul 2025
byJairia Dela Cruz
Twelve weeks of treatment with the aldosterone synthase inhibitor lorundrostat proved efficacious and safe for lowering blood pressure (BP) in adults with uncontrolled hypertension, including those who were resistant to treatment, according to the phase III Launch-HTN trial.
